Nadia Bayou, Research Associate in Medicine at Weill Cornell Medicine, shared a post on LinkedIn about a paper she co-authored with colleagues published in Cancer Cell International:
“I’m pleased to share our latest publication in Cancer Cell International!
‘Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer’
Our analysis highlights the dynamic heterogeneity of HER2 expression in metastatic breast cancer and supports the role of CTCs as a minimally invasive tool for real-time disease assessment.
Grateful to all co-authors, clinical collaborators, and especially to the patients who made this work possible.
Open-access on PubMed.”
Title: Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer
Authors: Nadia Bayou, Sarah Henretta, Laura Munoz-Arcos, Elisabetta Molteni, Caterina Gianni, Mara Serena Serafini, Eleonora Nicolò, Letizia Pontolillo, Brenno Pasto, Hunter Andrew Gaudio, Maroua Manai, Muhammad Maaz Khan Afghan, Jyothi Manohar, Olivier Elemento, Eleni Andreopoulou, Massimo Cristofanilli, and Carolina Reduzzi
You can read the Full Article in Cancer Cell International.
More posts featuring Nadia Bayou.